However, when combining CD38 scores in normal and cancer, we found that high expression of CD38 (above the median) in both normal and cancer tissues is significantly associated with a reduced risk of recurrence (p = 0.018) when compared to all other combinations (above median cancer and below median normal, below median cancer and above median normal, below median cancer and below median normal). Here, CD38 is linked to cancer.